Aqua Bio Technology ASA
Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is b… Read more
Aqua Bio Technology ASA - Asset Resilience Ratio
Aqua Bio Technology ASA (ABTEC) has an Asset Resilience Ratio of 1.88% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2023)
This chart shows how Aqua Bio Technology ASA's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Aqua Bio Technology ASA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr5.30 Million | 1.82% |
| Short-term Investments | Nkr178.57K | 0.06% |
| Total Liquid Assets | Nkr5.48 Million | 1.88% |
Asset Resilience Insights
- Limited Liquidity: Aqua Bio Technology ASA maintains only 1.88% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Aqua Bio Technology ASA Industry Peers by Asset Resilience Ratio
Compare Aqua Bio Technology ASA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Aqua Bio Technology ASA (2016–2023)
The table below shows the annual Asset Resilience Ratio data for Aqua Bio Technology ASA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 2.11% | Nkr5.02 Million | Nkr237.74 Million | -0.66pp |
| 2022-12-31 | 2.77% | Nkr1.86 Million | Nkr67.20 Million | -36.02pp |
| 2021-12-31 | 38.79% | Nkr13.36 Million | Nkr34.43 Million | +5.36pp |
| 2020-12-31 | 33.44% | Nkr5.43 Million | Nkr16.24 Million | -32.77pp |
| 2019-12-31 | 66.20% | Nkr6.88 Million | Nkr10.39 Million | +33.29pp |
| 2018-12-31 | 32.91% | Nkr3.27 Million | Nkr9.94 Million | -8.77pp |
| 2017-12-31 | 41.68% | Nkr20.46 Million | Nkr49.09 Million | -18.92pp |
| 2016-12-31 | 60.61% | Nkr43.29 Million | Nkr71.42 Million | -- |